Leigh A. Vosseller - 13 Sep 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Signature
s/ David B. Berger, Attorney-in-Fact for Leigh A. Vosseller
Issuer symbol
TNDM
Transactions as of
13 Sep 2021
Net transactions value
-$830,312
Form type
4
Filing time
15 Sep 2021, 17:01:44 UTC
Previous filing
31 Aug 2021
Next filing
17 Sep 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $188,600 +10,000 +163% $18.86 16,145 13 Sep 2021 Direct F1
transaction TNDM Common Stock Sale $804,938 -6,700 -41% $120.14 9,445 13 Sep 2021 Direct F2, F3
transaction TNDM Common Stock Sale $157,794 -1,300 -14% $121.38 8,145 13 Sep 2021 Direct F2, F4
transaction TNDM Common Stock Sale $244,780 -2,000 -25% $122.39 6,145 13 Sep 2021 Direct F2, F5
holding TNDM Common Stock 145 13 Sep 2021 Leigh A. Vosseller Trust F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $188,600 +10,000 +22% $18.86 55,160 13 Sep 2021 Common Stock 10,000 $18.86 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2021.
F3 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $120.00 to $120.67. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F4 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $121.01 to $121.95. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F5 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $122.04 to $122.71. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F6 The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
F7 The options vested as to twenty-five (25%) of the underlying shares on 6/14/2019, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F8 The expiration date for these options is 10 years from the date of grant.